ICON PLC — Investor Relations & Filings
ICON PLC is a global provider of outsourced development and commercialization services for the pharmaceutical, biotechnology, and medical device sectors. The company supports clients in accelerating the development of drugs and devices, offering a comprehensive suite of services that span the entire clinical lifecycle from "molecule to medicine." Core capabilities include consulting, early clinical and bioanalytical solutions, site and patient solutions, specialty laboratory services supporting precision medicine, and market access strategies covering pricing and reimbursement. ICON also delivers specialized biotech support, such as due diligence and asset valuation, alongside advanced cardiac safety solutions. The company integrates healthcare intelligence and technology, including artificial intelligence, to enhance clinical research processes.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 6-K - ICON PLC (0001060955) (Filer) | 2026-04-29 | English | |
| 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | |
| 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | |
| 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | |
| 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | |
| 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 38523041 | 6-K - ICON PLC (0001060955) (Filer) | 2026-04-29 | English | ||
| 32979428 | 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | ||
| 32979257 | 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | ||
| 32979034 | 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | ||
| 32979027 | 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | ||
| 32978975 | 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | ||
| 32979000 | 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | ||
| 32978992 | 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | ||
| 32978823 | 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | ||
| 32979004 | 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | ||
| 27010870 | 6-K Filing | 2026-01-07 | English | ||
|
2025
4 filings
| |||||
| 11036694 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 11036695 | Major Shareholding Notification 2025 | 2025-11-12 | English | ||
| 11036696 | 6-K | 2025-11-12 | English | ||
| 11036697 | Regulatory Filings 2025 | 2025-11-03 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for ICON PLC, but not for this combination of statement and period. Try a different combination.
| Line item | ! |
|---|---|
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
APURES CO., LTD.
Biotech firm providing MICROPIG models, bio-resources, and …
|
149300 | KR | Professional, scientific and te… |
|
Aran Research & Development (1982) Ltd.
A product design and development firm providing services fr…
|
ARAN | IL | Professional, scientific and te… |
|
Arch Biopartners Inc.
Developing novel drugs for acute kidney injury (AKI) and ch…
|
ARCH | CA | Professional, scientific and te… |
|
ARCHER MATERIALS LIMITED
Develops semiconductor devices for quantum computing and me…
|
AXE | AU | Professional, scientific and te… |
|
ARGENICA THERAPEUTICS LIMITED
Clinical-stage developer of neuroprotective drugs for acute…
|
AGN | AU | Professional, scientific and te… |
|
ARIUS Research Inc.
Discovery and development of targeted antibody therapeutics…
|
ARI | CA | Professional, scientific and te… |
|
AROVELLA THERAPEUTICS LIMITED
Develops off-the-shelf iNKT cell therapies for blood cancer…
|
ALA | AU | Professional, scientific and te… |
|
Artiva Biotherapeutics, Inc.
Develops allogeneic, off-the-shelf NK cell therapies for ca…
|
ARTV | US | Professional, scientific and te… |
|
ARVINAS, INC.
Clinical-stage biopharma developing therapeutics based on t…
|
ARVN | US | Professional, scientific and te… |
|
Asarina Pharma AB
A biotechnology company in liquidation, formerly focused on…
|
ASAP | SE | Professional, scientific and te… |
ICON PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30483/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30483 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30483 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30483 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30483}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ICON PLC (id: 30483)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.